Results 31 to 40 of about 280,908 (318)

How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?

Journal of Infection in Developing Countries, 2023
Introduction: We aimed to investigate the effects of the coronavirus disease 2019 (COVID-19) pandemic on the course and treatment of patients with inflammatory rheumatic musculoskeletal disease (iRMD) using biologic or targeted synthetic disease ...
Semih Gulle, Yesim Erez, Ali Karakas, Tuba Yuce Inel, Sinem Burcu Kocaer, Tuba Demirci Yildirim, Gercek Can, Ismail Sari, Merih Birlik, Fatos Onen   +9 more
doaj   +1 more source

Telerheumatology during the COVID-19 pandemic: Impact on clinical practice, education, and research

Indian Journal of Rheumatology, 2022
Telerheumatology, the use of telemedicine in the provision of rheumatology care, has been on the periphery of rheumatology practice for several years. However, the need for remote rheumatology service has emerged during the COVID-19 pandemic in order to ...
Su Ann Yeoh, Anastasia-Vasiliki Madenidou   +1 more
doaj   +1 more source

Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries [PDF]

, 2018
The increasing availability of biosimilar medicines in Middle Eastern regions may provide an opportunity to increase the number of rheumatology patients who have access to traditionally more expensive biologic medicines.
Bassel El Zorkany, Mohamed Mounir, Nizar Al Ani, Mounir, Mohamed, Almoallim, H. M., Hani Al Moallim, Uthman, Imad W., Imad Uthman, Elzorkany, Bassel, Al-Emadi, Samar Ai, El Dershaby, Yasser M., al-Saleh, Jamal Ali, Jamal Al Saleh, Samar Al Emadi, Yasser El Dershaby, Abdulateef, Nizar   +15 more
core   +1 more source

This is how the rheumatology events went in 2020

Global Rheumatology, 2020
Because of the pandemic, the plans for science events had to be changed from the usual face-to-face format to a virtual format in record time. Today we talk about the challenges that these events posed for their organizers at a global level.
Global Rheumatology by PANLAR
doaj   +1 more source

Adaptive trial designs in rheumatology: Report from the OMERACT special interest group [PDF]

, 2019
Objective. Adaptive trial design was developed initially for oncology to improve trial efficiency. If optimized for rheumatology, it may improve trial efficiency by reducing sample size and time. Methods.
Alten, Rieke, Christensen, Robin, van Hoogstraten, Hubert, Christensen, Robin; id_orcid, Choy, Ernest H., Boers, Maarten, Tam, Lai-Shan, Bykerk, Vivian, Simon, Lee S, Pickles, Tim, Choy, Ernest H, Simon, Lee S., Christensen, Jared   +12 more
core   +1 more source

World Arthritis Day

Global Rheumatology, 2020
Since 1996, October 12th is recognized as World Arthritis Day. A global initiative bringing people together to raise awareness of rheumatic and musculoskeletal diseases (RMDs), established by Arthritis and Rheumatism International (ARI) and managed by ...
Global Rheumatology by PANLAR
doaj   +1 more source

ABC of Rheumatology. [PDF]

Postgraduate Medical Journal, 2000
ABC of Rheumatology. 2nd Ed. Edited by Michael L Snaith. (Pp 90; £16.95 paperback.) BMJ Publishing Group, 1999. ISBN 0-7279-1385-9. ABC of Rheumatology was based on the excellent series published in the BMJ . This is the second edition of the book, which continues the successful formula of combining chapters dealing with common rheumatic disorders ...
openaire   +2 more sources

The Need to Innovate

Global Rheumatology, 2020
The concept of innovation is broad and its implications are diverse. But what is medical innovation and what are its developments? We will talk about this during our sessions of A Coffee for Rheumatology.
Global Rheumatology by PANLAR
doaj   +1 more source

Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study [PDF]

, 2009
Objective. Inflammatory arthritis in childhood is variable in terms of both presentation and outcome. This analysis describes disease activity in children with juvenile idiopathic arthritis (JIA) during the first year following presentation to a ...
Hyrich, Kimme L., Foster, H.E., Hyrich, K.L., Gardner-Medwin, J., Hyrich, Kimme L, Thornton, J., Lal, Sham D., Lal, S.D., Adib, Navid, Baildam, Eileen, Chieng, Alice, Davidson, J., Foster, Helen E., Foster, Helen E, Wedderburn, L.R., Gardner-Medwin, Janet, Lal, Sham D, Davidson, Joyce, Thomson, W., Wedderburn, Lucy R., Thornton, Judith, Baildam, E., Chieng, A., Adib, N., Thomson, Wendy, Wedderburn, Lucy R   +25 more
core   +1 more source

Literacy levels required to complete routinely used patient-reported outcome measures in rheumatology

, 2012
Objective. To assess the reading levels required to complete patient-reported outcome measures (PROs)commonly used in rheumatology clinical and research settings.Methods. Ten PROs written in English were evaluated.
Ryan, Sarah-Jane, Adams, Jo, Adams, J., Bradley, Sarah, Ryan, Sarah Jane, Bradley, S., Ryan, S.J., Chapman, Judith   +7 more
core   +1 more source